Mika K. Derynck
Director, Enliven Therapeutics, Inc.
Companies
- Enliven Therapeutics, Inc.Board member Feb 27, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Enliven Therapeutics, Inc. ELVN0 shares2Aug 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 4, 2026Sold 158,795 shares at $60.21 of Enliven Therapeutics, Inc.2
- Aug 4, 2026Exercised options 20,491 shares at $22.47 of Enliven Therapeutics, Inc.2
- Aug 4, 2026Exercised options 23,364 shares at $14.85 of Enliven Therapeutics, Inc.2
- Aug 4, 2026Exercised options 27,567 shares at $25.28 of Enliven Therapeutics, Inc.2
- Aug 4, 2026Exercised options 87,373 shares at $2.48 of Enliven Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2